These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 36281781)

  • 21. Pathophysiology of thrombotic thrombocytopenic purpura.
    Tsai HM
    Int J Hematol; 2010 Jan; 91(1):1-19. PubMed ID: 20058209
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Deficiency of ADAMTS13 in thrombotic thrombocytopenic purpura.
    Tsai HM
    Int J Hematol; 2002 Aug; 76 Suppl 2():132-8. PubMed ID: 12430913
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Deficiency of von Willebrand factor-cleaving protease in familial and acquired thrombotic thrombocytopenic purpura.
    Furlan M; Lämmle B
    Baillieres Clin Haematol; 1998 Jun; 11(2):509-14. PubMed ID: 10097823
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Von Willebrand factor, ADAMTS-13, and thrombotic thrombocytopenic purpura.
    Zhou Z; Nguyen TC; Guchhait P; Dong JF
    Semin Thromb Hemost; 2010 Feb; 36(1):71-81. PubMed ID: 20391298
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interactions of von Willebrand factor and ADAMTS13 in von Willebrand disease and thrombotic thrombocytopenic purpura.
    Budde U; Schneppenheim R
    Hamostaseologie; 2014; 34(3):215-25. PubMed ID: 25010251
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel mechanisms of action of emerging therapies of hereditary thrombotic thrombocytopenic purpura.
    Zheng XL
    Expert Rev Hematol; 2024 Jul; 17(7):341-351. PubMed ID: 38752747
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An IAP retrotransposon in the mouse ADAMTS13 gene creates ADAMTS13 variant proteins that are less effective in cleaving von Willebrand factor multimers.
    Zhou W; Bouhassira EE; Tsai HM
    Blood; 2007 Aug; 110(3):886-93. PubMed ID: 17426255
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In-vitro and in-vivo consequences of mutations in the von Willebrand factor cleaving protease ADAMTS13 in thrombotic thrombocytopenic purpura.
    Donadelli R; Banterla F; Galbusera M; Capoferri C; Bucchioni S; Gastoldi S; Nosari S; Monteferrante G; Ruggeri ZM; Bresin E; Scheiflinger F; Rossi E; Martinez C; Coppo R; Remuzzi G; Noris M;
    Thromb Haemost; 2006 Oct; 96(4):454-64. PubMed ID: 17003922
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hereditary Thrombotic Thrombocytopenic Purpura.
    Nusrat S; Beg K; Khan O; Sinha A; George J
    Genes (Basel); 2023 Oct; 14(10):. PubMed ID: 37895305
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Congenital thrombotic thrombocytopenic purpura in association with a mutation in the second CUB domain of ADAMTS13.
    Pimanda JE; Maekawa A; Wind T; Paxton J; Chesterman CN; Hogg PJ
    Blood; 2004 Jan; 103(2):627-9. PubMed ID: 14512317
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Congenital thrombotic thrombocytopenic purpura caused by new compound heterozygous mutations of the ADAMTS13 gene.
    Rank CU; Kremer Hovinga J; Taleghani MM; Lämmle B; Gøtze JP; Nielsen OJ
    Eur J Haematol; 2014 Feb; 92(2):168-71. PubMed ID: 24033710
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An enzyme immunoassay of ADAMTS13 distinguishes patients with thrombotic thrombocytopenic purpura from normal individuals and carriers of ADAMTS13 mutations.
    Zhou W; Tsai HM
    Thromb Haemost; 2004 Apr; 91(4):806-11. PubMed ID: 15045144
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thrombotic thrombocytopenic purpura and anti-thrombotic therapy targeted to von Willebrand factor.
    Zhou Z; Dong JF
    Curr Vasc Pharmacol; 2012 Nov; 10(6):762-6. PubMed ID: 22022775
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Hereditary form of thrombotic thrombocytopenic purpura].
    Hrachovinová I; Rittich S; Salaj P; Suttnar J; Dyr JE; Suláková T; Pták J; Dulícek P; Seeman T
    Cas Lek Cesk; 2006; 145(5):390-2. PubMed ID: 16755777
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ten candidate ADAMTS13 mutations in six French families with congenital thrombotic thrombocytopenic purpura (Upshaw-Schulman syndrome).
    Veyradier A; Lavergne JM; Ribba AS; Obert B; Loirat C; Meyer D; Girma JP
    J Thromb Haemost; 2004 Mar; 2(3):424-9. PubMed ID: 15009458
    [TBL] [Abstract][Full Text] [Related]  

  • 36. von Willebrand factor cleaving protease and ADAMTS13 mutations in childhood TTP.
    Schneppenheim R; Budde U; Oyen F; Angerhaus D; Aumann V; Drewke E; Hassenpflug W; Häberle J; Kentouche K; Kohne E; Kurnik K; Mueller-Wiefel D; Obser T; Santer R; Sykora KW
    Blood; 2003 Mar; 101(5):1845-50. PubMed ID: 12393505
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Advance in the diagnosis and treatment of hereditary thrombotic thrombocytopenic purpura].
    Liu W; Xiao Y
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2022 Apr; 39(4):442-446. PubMed ID: 35446985
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Single-nucleotide variations defining previously unreported ADAMTS13 haplotypes are associated with differential expression and activity of the VWF-cleaving protease in a Salvadoran congenital thrombotic thrombocytopenic purpura family.
    Kim B; Hing ZA; Wu A; Schiller T; Struble EB; Liuwantara D; Kempert PH; Broxham EJ; Edwards NC; Marder VJ; Simhadri VL; Sauna ZE; Howard TE; Kimchi-Sarfaty C
    Br J Haematol; 2014 Apr; 165(1):154-8. PubMed ID: 24433405
    [No Abstract]   [Full Text] [Related]  

  • 39. The potential therapeutic benefit of targeting ADAMTS13 activity.
    Eerenberg ES; Levi M
    Semin Thromb Hemost; 2014 Feb; 40(1):28-33. PubMed ID: 24338607
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular biology of ADAMTS13 and diagnostic utility of ADAMTS13 proteolytic activity and inhibitor assays.
    Shelat SG; Ai J; Zheng XL
    Semin Thromb Hemost; 2005 Dec; 31(6):659-72. PubMed ID: 16388417
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.